The Democratic Republic of the Congo has launched a record-breaking trial for two drugs, enrolling patients just six weeks after an outbreak was declared in the Ituri region.
The study is being conducted in the Ituri region
Jul 12, 2026
05:56 pm
What's the storyThe Democratic Republic of the Congo (DRC) has begun a groundbreaking clinical trial to test two experimental drugs for treating Ebola.
The study, which is being conducted in the Ituri region, comes just six weeks after the World Health Organization (WHO) declared an outbreak of the Bundibugyo strain of Ebola a public health emergency.
First patients enrolled in record-breaking Ebola treatment trial in DR Congo
First patients enrolled in record-breaking Ebola treatment trial in DRC
Clinical trials begin in DRC epicenter of Bundibugyo strain of Ebola
Clinical trials offer hope as Ebola outbreak accelerates
WHO launches first trial of antiviral to prevent Bundibugyo strain of Ebola
Interview: Clinical trial on Bundibugyo strain an important step in Ebola response, Africa CDC chief says
Ebola treatment facilities in DRC race to adapt to growing patient needs | Africanews
First patients have been enrolled in a Ebola treatment trial in the Democratic Republic of Congo as two drugs are being trialed…
A clinical trial for Ebola treatments targeting the current outbreak in the Democratic Republic of Congo has commenced, enrolling…
The Democratic Republic of Congo has launched a clinical trial of experimental Ebola treatments as the outbreak continues to…
A first ray of hope for Ebola patients in the Democratic Republic of the Congo as the trial of two potential treatments for the…
Clinical trials for treatments against Ebola Bundibugyo virus are ‘in a strong position’ to be launched quickly in the Democratic…
Two drugs are being trialled in the Ituri region in a programme set up just six weeks after the outbreak was declared, with hopes…
